Related Experiment Video
Updated: Jul 10, 2026

The Tail Suspension Test
Published on: January 28, 2012
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study
Lars Vedel Kessing1, Lars Søndergård, Kajsa Kvist
1Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, University of Copenhagen, Denmark. lars.kessing@rh.dk
Objectives:
To estimate adherence to lithium in a nationwide sample of all patients treated with lithium and to characterize adherence according to gender and age.
Methods:
Adherence to lithium was estimated using data obtained by linking Medicinal Product Statistics with the Danish Medical Register on Vital Statistics, identifying all persons who received lithium among the 5.3 million persons living in Denmark during the period 1995 to 2000 inclusive.
Results:
The median time to discontinuation of lithium was 181.0 days [95% confidence interval (CI) 135.7-181.0] and 25% of patients stopped treatment with lithium within 45.2 days. Adherence to lithium was significantly poorer for women (135.7 days; 95% CI 90.5-135.7) than for men (316.7 days; 95% CI 271.4-407.1) and for younger (18-39 years) and older (>or=60 years) patients compared to middle-aged patients.
Conclusions:
The results highlight the need for increased focus on long-term adherence to lithium with intensified psychological support, especially among younger and older female patients.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Drug Therapy
Antianxiety Medications
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Naturalistic Observations
Dosage Regimens: Partial Pharmacokinetic Parameters
